Clarithromycin Plus Bortezomib May Be Ineffective, Toxic in Multiple Myeloma
Researchers found that clarithromycin plus bortezomib does not confer any additional efficacy and is a toxic in patients with multiple myeloma.
Diagnosis & Disease Information
Optimal Management of Myeloma With Bortezomib
In this review of the role of bortezomib in the treatment of multiple myeloma, the researchers explain what nurses need to watch for in patients taking this drug.
Administration of bortezomib using Palindrome dialysis catheter access
Is it within the RN scope of practice to administer bortezomib using Palindrome dialysis catheter access in a multiple myeloma patient?
Study shows cause of and potential cure for aggressive leukemia
Excessive levels of interleukin-15 initiate large granular lymphocyte (LGL) leukemia, but also represent a promising therapeutic target.
Persistent headache plagues an immunocompromised patient
Imaging studies and laboratory tests were negative, but lumbar puncture revealed the cause of this patient’s unexplained neurologic symptoms.
Oncology Nurse Advisor Forum – November/December 2010
The forum answers questions about curcumin, MUGA scans, administering bortezomib, and more.
Highly-Effective Drug Regimen Helps Treat Multiple Myeloma Patients
Multiple myeloma patients experience high response rates when treated with a drug regimen consisting of 3 drugs, according to data presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.
- Loading...
Loading...
Loading... 
Loading...